Laurie Heilmann joins AltheaDx as a member of the advisory board and will assist with corporate strategy and commercialization efforts. A veteran life science executive, Laurie brings more than 30 years of executive leadership experience. Recent accomplishments include CEO and board member of Notable Labs, and CrownBio where she served as President of Global Life Science and Diagnostic Solutions, leading the transformational strategic development and commercialization of products/services to treat oncology, cardiovascular, and metabolic diseases. Additionally, Laurie is a board member for Agendia, a breast cancer diagnostic company.
Francis Mondimore, M.D. | Founding Director, Mood Disorders Clinic, Johns Hopkins Bayview Medical Center, Associate Professor of Psychiatry and Behavioral Sciences
Dr. Mondimore is a psychiatrist with over 30 years of experience treating people with psychiatric disorders. A graduate of the Johns Hopkins University School of Medicine, he also did his psychiatric training at Hopkins, where he is currently an Associate Professor in the Department of Psychiatry and Behavioral Sciences. In 2012 he established the Mood Disorders Clinic at the Johns Hopkins Bayview Medical Center, where he led a team of clinicians specializing in the care of persons with mood disorders until his retirement from clinical practice in 2019.
Michele Casoli Reardon, M.D. | Medical Director at MCPAP North (Massachusetts General Hospital for Children North Shore) and Associate Professor at Tufts Medical School
Dr. Reardon has over 25 years of experience in the medical field. She received her medical degree from Pennsylvania State University and completed a combined program in Pediatrics, Adult Psychiatry, Child Psychiatry at Brown University; she is Board Eligible/Board Certified in all three specialties. For the past 15 years, she has worked at Massachusetts General Hospital for Children at North Shore, holding various positions including 10 years as the Medical Director of the Adolescent and Adult Partial Psychiatric Hospital Program. Over the past five years, she has worked as the Medical Director for the Massachusetts Child Psychiatry Access Program. She also is part-time on the faculty at Tufts Medical School.
Jorge Garces, Ph.D. | President & Chief Scientific Officer, Epigenomics
Dr. Garces has over 20 years of management experience in the molecular diagnostics and life sciences industries. Prior to joining Epigenomics, he served as CEO and President of AltheaDx Inc. and previously at Enigma Diagnostics, Inc. in the same capacity. He was also Vice President and Site Operations Manager at Hologic, Inc., where he led the development and submission to FDA for approval of their Cystic Fibrosis and HPV products. He earned his doctorate in Cell and Molecular Biology from the City University of New York and received an MBA from the Kellogg Graduate School of Management at Northwestern University.